Reminder: You are viewing our sharing site. Content may differ from our live site.
Skip to main content

# Osteopenia - Whole blood and components

## Essential information

Obligatory

  Must not donate if:

  The donor is being treated with systemic monoclonal antibody therapy, e.g. denosumab (Prolia®). See Monoclonal antibody therapy and other biological modalities.

Discretionary

  If the cause is not of itself a reason to defer, even if on treatment to prevent or treat (other than denosumab), accept.

## Supporting information

See if relevant
  - Disabled donor
  - Malignancy
  - Monoclonal antibody therapy and other biological modalities
  - Steroid therapy
  - Vitamins and other nutritional supplements
Additional information

  Osteopenia occurs when there is decreased mineralisation (mainly lack of calcium) of bone. It can occur for many reasons so it is important to ensure that it is not associated with a condition that would require a potential donor to be deferred.

Version details:

  WB-DSG Edition 203 Release 71 (02 May 2024)

BETA

We recently updated this website. Help us improve it – give your feedback (opens in new tab)